Placebo-controlled, blinded trial
n = 156 · Knee replacement · NIH-funded · The Journal of Arthroplasty
- 26%less opioid use in the first 24 hours
- 19%shorter hospital stay (20.8 vs 25.7 hours)
Drug-free · Reusable · No electricity
Pain is universal. Access to relief is not.
Pain Relief International builds distributed, reusable access to pain relief — restoring the ability to work, learn, and care for others without dependence on electricity, consumables, or continuous care systems.
5.5 Billion
people lack access to pain relief, limiting global participation
- 501(c)(3) nonprofitEIN 81-2500234
- GuideStar Transparency SealOpen, verified reporting
- NIH-funded trialPlacebo-controlled, blinded
- FDA low-risk designationOver-the-counter use
The global burden
Pain is the world's leading cause of disability
“Burden” is not an abstraction. It means function lost: the field not worked, the class not attended, the child not carried, the shift not finished.
1.71B
people live with musculoskeletal conditions — the leading contributor to disability worldwide
619M
people live with low back pain, projected to reach 843 million by 2050
149M
years lived with disability from musculoskeletal conditions, every year
$635B
a year in treatment and lost productivity from chronic pain in the U.S. alone (upper estimate)
Sources: Global Burden of Disease study (IHME), published in The Lancet journals; Institute of Medicine ($560–635B estimate).
Why it matters
Pain doesn't just hurt. It changes lives.
Pain affects more than the person living with it. It affects families, workplaces, schools, healthcare systems, and entire communities. Relief changes what people are able to do.
- 01
Back to Work
Untreated pain reduces productivity, weakens local economies, and limits national output.
- 02
Back to School
Students in pain miss school, lose focus, and fall behind — reducing long-term opportunity.
- 03
Better Recovery
Helps people recover sooner and return to everyday life, easing strain on health systems.
- 04
Stronger Families
When caregivers are in pain, entire households are affected. Relief protects daily family function.
- 05
Stronger Communities
Pain reduces mobility, productivity, and response capacity at scale. Healthy communities begin with healthy people.
A better model for low-resource settings
Relief that works where systems don't reach
The world's default answers to pain — medication, consumables, clinic-based care — all assume infrastructure. For hundreds of millions of people, those assumptions fail.
Traditional pain reliefPain Relief International
Requires trained providersSimple, self-managed use
Restricted to clinical settingsWorks at home and in the community
Recurring procurement and supply chainsFunded once, works for years
Needs pharmacies, power, or refillsNo electricity, batteries, or consumables
Opioid-class medicines carry dependency riskDrug-free — no overdose risk
Hard to maintain consistent useEasy to use consistently, shareable at home
Our solution
Designed for real-world deployment
Deployments are enabled by NeuroCuple® passive nano-capacitive technology — a reusable, drug-free device designed to function without electricity, consumables, or continuous medical supply chains.
PRI 4x4 Deployment UnitThin, flexible, reusable for years
No doctors. No prescriptions.
No clinical staff required. Deployable by trained local personnel anywhere.
No electricity required
Works without batteries, wires, charging, or external power.
No consumables
Avoids recurring supply-chain dependence.
Reusable for years
Long functional life reduces cost per beneficiary.
Household shareable
One device can support repeated use across a family.
Drug-free
Supports pain relief without adding pharmaceutical burden or overdose risk.
Clinical evidence
Two peer-reviewed randomized trials
NeuroCuple® has been evaluated in two randomized clinical trials at the University of Pittsburgh Medical Center, including a placebo-controlled, blinded trial funded by the National Institutes of Health.
Randomized pilot study
n = 69 · Knee & hip replacement · Journal of Clinical Medicine
- 52%fewer patients requested an opioid refill after discharge
- 41%lower pain at rest over 30 days
Both studies were in postoperative (surgical recovery) settings. Humanitarian deployments are measured through their own program reporting — devices delivered, training completed, usage tracked — not borrowed clinical claims.
Read the full evidenceImpact that multiplies
See what your support deploys
Because each device is durable, reusable, and drug-free, the impact continues for years after the initial deployment.
- Devices deployed
- 50,000
- People supported
- 50,000+
- Cost per device, delivered
- $20
$20 per device, delivered, at program scale — $1,000,000 deploys 50,000 devices. Devices are shareable within a household, so cost per beneficiary keeps falling after the budget is spent.
Request a structured proposalPrograms
Designed for measurable impact
Workforce Productivity & Economic Participation
Keeping people active in work, education, and daily life by reducing the impact of untreated pain on participation and output.
Primary Healthcare System Support
Reducing patient burden and improving care delivery without adding strain to clinical infrastructure or supply chains.
Women's Health & Workforce Participation
Supporting women with menstrual and musculoskeletal pain to improve attendance, income stability, and maternal health.
Veterans & Workforce Recovery
Non-pharmacologic self-management tools that support continued activity and independence.
Rural & Low-Resource Communities
Enabling self-treatment where medical infrastructure is limited.
Local Manufacturing Partnerships
Building regional production capacity to strengthen economic sustainability and reduce distribution barriers.
How deployment scales
From pilot to national program
Deployed through structures governments and partners already operate — community health workers, school-adjacent programs, and existing distribution networks — with reporting at every stage.
- Phase 1
Pilot
A defined population and geography, deployed through existing channels with training and baseline measurement — designed to produce decision-grade data.
- Phase 2
Regional scale
Proven pilots expand through the Global Pain Relief Initiative, with train-the-trainer capacity that stays local.
- Phase 3
System integration
Deployment folds into national programs — school health, maternal health, workforce, disaster preparedness.
Find your way in
Partner on the response
Governments & Ministries
A deployment framework for public health systems, development banks, and bilateral programs.
Request a briefingFoundations & Funders
Structured, measurable programs with unit economics, timelines, and deployment reporting.
Fund a deploymentNGOs & Humanitarian Partners
Add drug-free relief to programs you already run — devices travel flat and deploy with existing distributions.
Partner with usOpioid Settlement Partners
Reusable, non-opioid pain care with training and outcome reporting for public health and treatment programs.
Explore the model
Stories & research
From the field
- Deployment
Scaling pain relief in real-world conditions: 3,500 devices deployed in Dubai
How reusable, drug-free relief was distributed at scale without infrastructure or supply chains.
Read story - Education
How period pain affects school attendance and learning
Recurring pain contributes to missed school days and reduced learning outcomes worldwide.
Read story - Data
The global burden of musculoskeletal pain
WHO and IHME data on pain, disability, and participation — over 1.7 billion people affected.
Read story
FAQ
Frequently asked questions
Still have a question about the device, deployments, or giving? We'd love to hear from you.
What does Pain Relief International do?
Pain Relief International distributes reusable, long-lasting, drug-free pain relief technology to underserved communities, working with ministries, NGOs, and community health workers.
Does it require electricity?
No. It requires no batteries, wires, charging, or external power.
Is it reusable?
Yes. The device is designed for long functional life and repeated use, and can be shared within a household.
Can it be used in rural environments?
Yes. It is specifically designed for low-resource and infrastructure-limited settings, including refugee and disaster-affected areas.
Is there clinical evidence?
Two peer-reviewed randomized trials at UPMC, including an NIH-funded placebo-controlled trial, found reduced pain at rest, reduced immediate opioid use, and earlier discharge after surgery. The studies covered postoperative recovery, not chronic pain or community settings.
Is the device regulated?
The device holds a U.S. FDA low-risk device designation for over-the-counter use. It is a comfort-support product and is not intended to diagnose, treat, cure, or prevent any disease.
Why is pain relief a development issue?
Untreated pain reduces workforce participation, disrupts education, increases healthcare use, and can deepen poverty.
Can organizations sponsor deployments?
Yes. Pain Relief International works with donors, NGOs, government agencies, and community partners to support deployment, training, and impact measurement.
Restore possibility
Remove the pain. Unleash the possibilities®
Investments in Pain Relief International enable sustained, community-level access to drug-free pain relief — not a single-use intervention.
